Myelodysplastic Syndromes (MDS)

Lukasz Gondek, M.D., Ph.D.

Institution
Johns Hopkins University School of Medicine
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
About
Dr. Gondek is a current Evans Fellow at Johns Hopkins University in the Department of Oncology, working with Dr. Amy Dezern on research related to signaling pathways in MDS stem cells. Dr. Gondek explained that the mechanism of progression in MDS is poorly understood, and he hopes through his work to clarify some of the factors that contribute to progression. He is the Principal Investigator on one pilot project currently underway within the MDS Clinical Research Consortium, working with a particular signaling pathway named the Hedgehog pathway. Dr. Gondek describes the Hedgehog (Hh) pathway

David Margolis, MD

Institution
Children’s Hospital of Wisconsin
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric
About
David Margolis, MD, received his medical degree from the University of Wisconsin-Madison in 1989. He is currently a professor of pediatrics at the Medical College of Wisconsin, located in Milwaukee, and is program director of Children’s Hospital of Wisconsin’s Blood and Bone Marrow Transplant Program. His clinical and research interests include taking care of children and young adults with aplastic anemia as well as alternative donor blood and bone marrow transplants for children and young adults with aplastic anemia, sickle cell anemia and leukemia.

Blood Transfusion Safety and Risks

Negative side effects of blood transfusion therapy are uncommon. Blood banks, hospitals, and health-care providers take many precautions to minimize risks before each blood transfusion.

Blood banks test each unit of blood to find out its ABO type and Rh status. In the United States, after a hospital laboratory receives a blood unit from the blood bank, the laboratory tests the unit again.

 

Guillermo Garcia-Manero, MD

Institution
Department of Leukemia at MD Anderson Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
My main academic and clinical objective is to, if not cure, at least contribute to significantly better outcomes for patients with Myelodysplastic Syndromes (MDS). I am the Chief of the Section of MDS in the Department of Leukemia at MD Anderson Cancer Center. I have built this into the largest clinical program of its class. One hundred percent of my research and clinical effort is devoted to patients with MDS.

Christopher Cogle, MD

Institution
University of Florida Health Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
About
Dr. Cogle is an associate professor of medicine at the University of Florida, Gainesville. He has clinical and research expertise in myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and allogeneic hematopoietic cell transplant. Dr. Cogle leads a research laboratory that studies the biology of MDS and AML, and his group has successfully translated his discoveries into new treatments for patients. Dr. Cogle’s goal is to fi nd cures for MDS and leukemia, educate patients and providers about the distinct heterogeneity of these diseases, educate policy makers that blood cancers are a
Subscribe to Myelodysplastic Syndromes (MDS)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.